Johnson & Johnson Intangible Assets

Johnson & Johnson (JNJ) currently reports a intangible assets of $48B as of June 2026. That compares with $50B in the prior-year period — down 3.2% year over year. Use the charts on this page to explore Johnson & Johnson's intangible assets history and peer comparisons.

Johnson & Johnson's intangible assets decreased from $50B to $48B — a 3.2% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Johnson & Johnson reported $48B in intangible assets as of June 2026. That compares with $50B in the prior-year period — down 3.2% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current intangible assets of $48B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Johnson & Johnson, and consider following JNJ for alerts when major investors trade the stock.

Johnson & Johnson is classified in the Healthcare sector. On intangible assets, it currently shows $48B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing JNJ with unrelated industries.